CHINA SECURITIES REGULATORY COMMISSION

    Securities / Derivatives

    China Issues Rules for Hainan Cross-Border Asset Management Pilot

    By Manesh Samtani | 23/07/2025

    New implementation rules allow foreign individuals and institutions to buy onshore products via Hainan, a key step in opening up the free trade port.

    Securities / Derivatives

    China Issues New Accounting Guidance to Curb Financial Fraud

    By Editors | 19/07/2025

    The CSRC has clarified eight complex accounting issues, including for convertible bonds and credit insurance, to improve disclosure quality.

    Securities / Derivatives

    Shanghai Exchange Launches ‘Growth Tier’ for Unprofitable Tech Firms

    By Editors | 16/07/2025

    New STAR Market tier for pre-profit tech companies goes live with 32 firms, featuring distinct delisting rules and enhanced investor risk warnings.

    ESG / Sustainability

    China Extends Green Finance Project Catalogue to Cover Loans

    By Editors | 16/07/2025

    The updated green finance catalogue unifies project standards for loans and bonds, expanding its scope to cover new industries.

    Securities / Derivatives

    China Extends Programmatic Trading Reporting Rules to Foreign Investors

    By Manesh Samtani | 14/07/2025

    New rules from Shanghai and Shenzhen exchanges will require international investors using the Stock Connect scheme to report their algorithmic trading activities from January 2026.

    Securities / Derivatives

    Dalian Exchange Launches Benzene Futures and Options

    By Editors | 09/07/2025

    The new derivatives aim to provide risk management tools for the world's largest aromatics producer and enhance China's pricing influence.

    Securities / Derivatives

    China Mandates Stricter ETF Risk Controls for Fund Managers, Brokers

    By Editors | 08/07/2025

    New rules require fund managers to enhance operational controls and brokers to monitor high-risk client trading, amid rapid market growth.

    Securities / Derivatives

    Shanghai STAR Market Approves First Unprofitable IPO Under Revived Rules

    By Editors | 04/07/2025

    Wuhan-based drugmaker Healthgen Biotechnology got the approval, signalling renewed policy support for innovative, pre-revenue technology and life sciences firms.

    image

    Securities / Derivatives

    Shanghai and Astana Exchanges Sign New Cooperation Pact

    By Editors | 02/07/2025

    The agreement aims to enhance cooperation in areas such as stock and debt product development and market promotion.

    image

    China Revises Regulations for Money Brokerage Companies

    By Editors | 29/06/2025

    The revised regulations expand the permitted business scope for money brokerage firms, allowing them to facilitate transactions in more markets.

    JOIN OUR NEWSLETTER

    A daily selection of top stories from the Regulation Asia editorial team